| New Highs 48 | |||
| COMPANY | SYMBOL | HIGH | VOLUME |
| ------- | ------ | ---- | ------ |
| ADMA Biologics | ADMA | 25.67 | 2,662,281 |
| ANI Pharmaceuticals | ANIP | 71.85 | 84,394 |
| Alpha Arch Intl Qunt Val | IVAL | 27.25 | 17,693 |
| American Public Education | APEI | 25.76 | 95,991 |
| Atlanticus Nts 2026 | ATLCL | 24.75 | 5,898 |
| Beacon Roofing Supply | BECN | 124.31 | 299,703 |
| Bleichroeder Acqn I Cl A | BACQ | 10.10 | 300 |
| Cantor Equity Partners I | CEPO | 11.69 | 311,473 |
| Defiance Tgt 2X Lg RGTI | RGTX | 28.59 | 46,189 |
| Defiance Tgt 2X Lg RKLB | RKLX | 29.03 | 66,579 |
| Defiance Gold Enh Opt | GLDY | 20.69 | 1,906 |
| Direxion Dly BA Bull 2X | BOEU | 31.68 | 15,154 |
| Direxion Dly NFLX Bull 2X | NFXL | 52.00 | 57,030 |
| Exagen | XGN | 6.34 | 37,636 |
| First Capital | FCAP | 49.48 | 1,997 |
| FT S&P Intl Div Aristo | FID | 17.95 | 2,987 |
| Gesher Acquisition II | GSHRU | 10.08 | 300 |
| Gl X MSCI SuperDivi | EFAS | 16.51 | 2,285 |
| GrShr 2x Long LCID Daily | LCDL | 30.89 | 419 |
| GrShr 2x Long RIVN Daily | RVNL | 34.08 | 1,410 |
| HCM II Acquisition | HOND | 11.19 | 7,384 |
| Healthcare Services | HCSG | 13.90 | 50,456 |
| Hennessy Cap Inv VII | HVII | 9.95 | 241 |
| Inflection Point Acqn III | IPCXU | 10.15 | 224,321 |
| Invsc DW Dev Markets Mntm | PIZ | 41.00 | 2,106 |
| iShares Global Infra | IGF | 56.45 | 162,186 |
| iSh MSCI Europe Finls | EUFN | 29.87 | 71,027 |
| Lazard Japanese Eq ETF | JPY | 27.54 | 734 |
| Leverage 2X Lg PLTR Dly | PLTG | 16.68 | 9,054 |
| Leverage 2X Lg PYPL Dly | PYPG | 16.46 | 1,881 |
| Marex Group | MRX | 43.15 | 126,254 |
| Netflix | NFLX | 1110.61 | 827,178 |
| New Providence Acqn III | NPACU | 10.08 | 327,189 |
| Oriental Culture Holding | OCG | 4.18 | 6,350 |
| REX Bitcoin Corp Trea | BMAX | 28.91 | 1,672 |
| Radius Recycling | RDUS | 29.30 | 45,455 |
| Regulus Therapeutics | RGLS | 3.04 | 474,366 |
| SPAC & New Issue ETF | SPCX | 25.00 | 857 |
| StoneX Group | SNEX | 88.75 | 22,476 |
| Take-Two Interactive | TTWO | 229.00 | 282,607 |
| ThredUp | TDUP | 4.47 | 473,041 |
| Titan Acquisition | TACHU | 10.05 | 227 |
| Tradr 2X Long APP Daily | APPX | 27.64 | 8,103 |
| Trailblazer Merger I Rt | TBMCR | 0.3800 | 6,051 |
| Trailblazer Merger I Cl A | TBMC | 11.70 | 3,521 |
| VeriSign | VRSN | 279.94 | 141,274 |
| Zentek | ZTEK | 1.34 | 23,625 |
| Zscaler | ZS | 221.50 | 728,690 |
| New Lows 21 | |||
| COMPANY | SYMBOL | LOW | VOLUME |
| ------- | ------ | ---- | ------ |
| AIFU ADR | AIFU | 0.1101 | 357,937 |
| Aptevo Therapeutics | APVO | 0.6010 | 186,408 |
| Beyond Meat | BYND | 2.48 | 427,776 |
| Creative Global Tech | CGTL | 1.15 | 889,368 |
| Defiance Tgt 2X Shrt SMCI | SMCZ | 12.74 | 69,379 |
| Direxion Dly BRKB Bear 1X | BRKD | 21.45 | 616 |
| Direxion Dly NFLX Bear 1X | NFXS | 15.11 | 69,552 |
| Direxion Dly PLTR Bear 1X | PLTD | 11.85 | 617,244 |
| Durect | DRRX | 0.6000 | 91,949 |
| Everbright Digital Hldg | EDHL | 3.51 | 11,851 |
| HCW Biologics | HCWB | 6.65 | 16,106 |
| Hall of Fame Resort & Ent | HOFV | 0.6212 | 21,364 |
| Intensity Therapeutics | INTS | 0.5000 | 406,821 |
| Klotho Neurosciences Wt | KLTOW | 0.0135 | 1,095 |
| LQR House | YHC | 2.06 | 45,633 |
| LakeShore Biopharma | LSB | 1.20 | 3,991 |
| Mobile-health Netwk Solns | MNDR | 1.31 | 30,245 |
| Phoenix Asia Holdings | PHOE | 3.13 | 99,152 |
| Repay Holdings | RPAY | 4.05 | 355,762 |
| Spruce Biosciences | SPRB | 0.0876 | 3,682,434 |
| WeRide ADR | WRD | 6.21 | 3,552,855 |
| Source: Dow Jones Market Data |
(END) Dow Jones Newswires
April 28, 2025 10:20 ET (14:20 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.